St. Elizabeth Healthcare
Edgewood, Kentucky 41017
17 studies enrolling now · 46 studies all time
What they study most
Acute Myocardial Infarction, Advanced or Metastatic Solid Tumors, Atherosclerotic Cardiovascular Disease, Biliary Tract Cancer, Breast Adenocarcinoma, Breast Cancer, Breast Neoplasms, COVID-19, Cardiovascular Disease, Cervical Cancer, Colorectal Cancer, Coronavirus Disease 2019 (COVID-19) Pneumonia
Studies at this site
- A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma — Recruiting now
- Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression — Recruiting now
- A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer — Recruiting now
- A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer — Recruiting now
- Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors — Recruiting now
- ELEVATE High-Risk PCI Pivotal Study — Recruiting now
- Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Health Services Research Intervention — Recruiting now
- Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Implementation — Recruiting now
- Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) — Recruiting now
- Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET — Recruiting now
- Study of PF-07248144 in Advanced or Metastatic Solid Tumors — Recruiting now
- Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome — Recruiting now
- A Phase 1 Study of LNCB74 in Advanced Solid Tumors — Recruiting now
- Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors — Recruiting now
- AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM — Recruiting now
- Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma — Available (expanded access)
- Selatogrel Outcome Study in Suspected Acute Myocardial Infarction — Enrolling by invitation
- (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer — Running, not enrolling
- Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca — Running, not enrolling
- Instylla HES Hypervascular Tumor Pivotal Study — Completed
- RegoNivo vs Standard of Care Chemotherapy in AGOC — Completed
- Optimizing Pharmacologic Treatment for Neonatal Opioid Withdrawal Syndrome (OPTimize NOW): A Symptom-Based Dosing Approach — Completed
- Alleviant ALLAY-HF Study — Enrolling by invitation
- CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in Lung — Running, not enrolling
- Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment — Running, not enrolling
- Mitral Valve Repair With the Chord-X System: A Long Term Evaluation — Starting soon
- Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery — Completed
- Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma — Running, not enrolling
- A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression — Completed
- A Randomized Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTORION-INITIATE) — Completed
- BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma — Running, not enrolling
- Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator — Completed
- Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients — Completed
- An Analysis of Treatment Timelines for Lung Cancer Patients Across System Evolutions — Completed
- A Review of Low-Dose CT Lung Cancer Screenings in a Community-Based Healthcare System With High Incidence — Completed
- Batiraxcept (AVB-S6-500)/Placebo in Combination With Paclitaxel in Patients With Platinum-Resistant Recurrent Ovarian Cancer — Stopped early
- Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: "Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C" — Completed
- Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C" — Completed
- The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection — Completed
- DyeVert™ System for Contrast Monitoring in At-Risk Patients Undergoing Angiography: A Real-World Registry — Status unconfirmed
- Strategic Management to Optimize Response To Cardiac Resynchronization Therapy — Completed
- Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19 — Status unconfirmed
- Impact of an Intensive Monitoring Strategy in Symptomatic Patients With Suspected Arrhythmia — Completed
- The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux Disease — Completed
- Determining the Sensitivity of Sentinel Lymph Nodes Identified With Robotic Fluorescence Imaging — Completed
- Sensible Medical Innovations Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients — Stopped early